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Sarcosine, an isomer of L-alanine, has been proposed as a prostate cancer progression
biomarker [1]. Both compounds are detected in urine, where the measured sarcosine/alanine
ratio has been found to be higher in prostate biopsy-positive group versus controls. We present
here preliminary evidence showing that urine samples spiked with sarcosine/alanine can be
partially resolved in 3 min via tandem differential mobility analysis-mass spectrometry
(DMA-MS). Based on the calibration curves obtained for two mobility peaks, we finally estimate
their concentration ratio in urine. (J Am Soc Mass Spectrom 2010, 21, 1129–1132) © 2010
American Society for Mass SpectrometryProstate cancer is a leading cause of death among themale population. Sarcosine, an isomer of alanine,was recently proposed as a prostate cancer progres-
sion biomarker [1]. In particular, the sarcosine/alanine
ratio was found to be significantly higher in urine derived
from biopsy-positive prostate cancer patients compared
with biopsy-negative controls. This finding could be an
important milestone for noninvasive diagnosis of prostate
cancer. The technique used in [1] to assess sarcosine levels
in urine is GC-MS. GC-MS is a time-consuming proce-
dure, so the development of faster separation alternatives
would be highly desirable if the method were to be
applied in large-scale clinical practice. Ion mobility
spectrometry-mass spectrometry (IMS-MS) can repre-
sent such an alternative.
Most IMS-MSwork has relied on linear drift tubes. The
majority of previous IMS-MS studies of biomolecules have
dealt with proteins [2], with fewer studies targeting the
metabolome [3] as we do here. Differential mobility ana-
lyzers (DMAs) separate species of different mobilities
using space-dispersion rather than time-dispersion [4].
This feature makes them easier to combine with second-
stage analyzers than traditional linear drift tubes. We
explore here the ability of a DMA-MS system to discrim-
inate the isomers L-alanine and sarcosine in urine.
Experimental
The coupling in series of a DMA (SEADM) to a commer-
cial QTOF (SCIEX’s QStar, Concord, ON, Canada) for
mobility and mass measurement was described in detail
elsewhere [4, 5]. We electrosprayed our samples in posi-
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parameters were: capillary 360 m o.d., 50 m i.d., length
22 cm, driving pressure 75 mbar, and 3.8 kV. The ions
entered the separation region propelled by an electric field
and against a counterflow gas (0.2 L/min). Sheath gas
flow was kept constant, and the classification voltage was
scanned. Typical operation sheath flow rates were in the
range of 1,000 L/min, and scanning voltages in the range
of 1.0–2.6 kV. Mobility-selected ions entered the mass
spectrometer to be analyzed according to their m/z.
We first analyzed sarcosine and L-alanine standards
separately (100 M in methanol, formic acid 2 %), and
subsequently we analyzed them as a mixture (50 M
each in methanol, formic acid 2 %). Upon characteriza-
tion of the standards we analyzed urine samples spiked
with alanine or sarcosine. In this case, the spiked
samples were diluted (1:9:0.3 urine:methanol:formic
acid) and were electrosprayed without further sam-
ple preparation. Collision induced dissociation (CID)
experiments were performed selecting a desired mo-
bility by fixing the DMA voltage, and then using the
QStar standard MS-MS methods, at a collision energy
of 10 V.
Results and Discussion
Standards
Figure 1 shows the mobility spectra of protonated
L-alanine and sarcosine (100 M; m/z 90.06  0.01 for
both), with the tetraheptylammonium ion used as in-
ternal standard in both samples (THA 10 M; m/z
410.14  0.01), in N2 as drift gas. Note that for both
experiments the THA peak appears overlapped, while
the sarcosine and L-alanine profiles are partially dis-
placed. Measured resolution for the THA peak was 42,
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will be discussed below). The insets show the corre-
sponding CID spectra of the most abundant ion in the
ion-mobility spectrum, showing the same characteristic
fragment at m/z 44.05 for both isomers. This is in excellent
agreement with the database www.massbank.jp. There-
fore, because there is no characteristic fragment that
is isomer-specific, clearly MS/MS alone does not
suffice to discriminate them in a mixture, and a
previous separation stage is needed. The ion at m/z
44.05 corresponds to the immonium ion derived by
loss of H2O  CO [6]. Note finally that in contrast
with drift tubes, fragmentation studies of a mixture of
isomers are done by simply selecting their mobility in
the DMA, removing isomers of different mobilities
before mass analysis.
In contrast with the THA well-defined peak, the
mobility spectra for sarcosine and alanine display mul-
tiple features apart from the main, high mobility peak.
In an attempt to identify these mobility features, we
also performed CID experiments on them, all of which
showed the same fragmentation pattern. For this rea-
son, we believe the lower mobility peaks are simply
clusters of either sarcosine or alanine with solvent
molecules that do not survive the transition between
atmospheric pressure (DMA) and low pressure (MS).
They also include contributions from dimers and trim-
ers dissociating between the mobility and the mass
analysis. We have monitored these (m/z 179 dimer and
m/z 268 trimer) in another series of experiments (not
shown), and they make a minor contribution to the m/z
90 mobility spectrum, accounting for some small fea-
tures in the long, low mobility tail.
Another advantageous feature of DMAs is that they
operate in the linear regime (i.e., weak electric field).
The electrical mobility of the THA ion was previously
characterized in air at 20 °C [7], so we spiked the
Figure 1. Mobility spectra in N2 for alanine, sarcosine and THA

(the latter is spiked in both solutions). The insets display the
MS/MS spectra from the dominant ion in the mobility spectrum.sarcosine/alanine solutions with this internal standardand ran the samples in air (Figure S1 Supplemental
Material, which can be found in the electronic version of
this article). We monitored the temperature at the wall
at the DMA exit, which was 31 °C for both alanine and
sarcosine runs shown in Figure S1. With this measure-
ment and an estimation of the heating due to the
dynamic pressure wasted or isentropically recovered in
the diffuser (efficiency of50 %), we can approximately
estimate a 26 °C temperature in the classification region.
Measured mobilities for sarcosine and alanine, cor-
rected to 20 °C as KT1/2 in air at 1 atm, were 1.94 and
1.89 cm2 V1s1, respectively. It is interesting to note
that even though these ions approach the mobility
attributable to polarization forces alone, given by the
polarization limit (2.2 cm2 V1s1) [8], we still
observe a size effect that enables their separation.
This is in accordance with Johnson et al. [9], who
measured a reduced mobility (K0) in N2 of 1.982 and
1.821 cm2 V1s1 for sarcosine and -alanine, respec-
tively. These data indicate that IMS-MS may become
an attractive analytical approach for metabolic pro-
filing, even for the smallest target molecules.
It is well known that an appropriate selection of the
drift gas results in an improvement of separability. As
shown in Figure S1, the separation in air is less efficient
than in N2, and we also tried the separation in CO2,
again with worse separability than in N2. This is in
agreement with the separation of sarcosine and -ala-
nine in [9]. Therefore, all subsequent data are for N2 as
drift gas. Note finally that the mobility spectra in Figure
1 show less low-mobility features than those of Figure
S1. We found that the temperature plays a critical role
in the profile of the mobility spectra. Spectra from
Figure 1 were recorded at 27–28 °C at the DMA exit (it
was 31 °C in Figure S1), and they show a dominating
high mobility peak and much weaker low mobility
peaks, whereas at 45 °C we observed an unresolved
broad peak containing several mobilities. Because the
main peak of interest here is the one of highest mobility,
which most likely corresponds to the bare ion, we
restricted DMA operation below 32 °C.
Therefore, we conclude from these preliminary ex-
periments that the mobility of sarcosine (based on the
highest mobility peak) in N2 is 4.5 % higher than that
of L-alanine.
Figure S2 shows the mobility spectra recorded at
increasing sheath gas flow rate (i.e., increasing resolu-
tion) of an equimolar mixture (50 M) of both isomers.
One can observe how, at increasing resolution, the main
broad peak tends to split into two peaks corresponding
to sarcosine and alanine. Note finally that during these
series of experiments, we lacked an extension of the
DMA diffuser that provides additional dynamic pres-
sure recovery. As a result, the system tended to heat
over 35 °C even at moderate gas speeds. For this reason,
we were forced to operate at slightly lower resolutions
than maximum capacity.
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Once we assessed the capabilities of the system to
separate both standards, we tested its response to real
urine samples. Figure 2a displays the resulting mobility
spectrum (m/z 90.05–90.07) of a diluted urine sample
(bottom pane). The same sample was spiked with
sarcosine or alanine at increasing concentrations (range
24–87 M). Three main features around 1.24 (A1), 1.35
(A2), and 1.45 (A3) kV consistently increased at increas-
Figure 2. (a) Top: mobility spectra for a urine
sarcosine at increasing concentrations. (b) Bott
features associated to both isomers in (a).ing alanine concentration. Spiking with sarcosine
clearly increases a shoulder at 1.20 (S1) kV over A1
and two more features at 1.30 (S2) and 1.44 (S3) kV. To
provide further evidence of the identity of the peaks, we
performed MS/MS experiments. The insets show the
CID spectra obtained by fixing the DMA voltage to
select the highest mobility ion (S1 or A1) for the most
concentrated sarcosine and alanine-spiked samples.
Both product-ion spectra show the characteristic frag-
le, unspiked and spiked with either alanine or
calibration curves obtained for the main threesamp
om:
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the latter also shows a minor peak at m/z 61 from an
unknown interference. Ions corresponding to the peaks
labeled as 2 and 3 showed the same CID pattern as that
for 1, indicating that they are sarcosine/alanine clusters,
although they remain to be fully characterized.
Figure 2b collects the maximum intensity of the
peaks considered as a function of the spiked concentra-
tion. It suggests a reasonable linearity for most of them,
with some scattered data. Note that each sample was
only run once and that we have discarded the most
concentrated S1 peak because, for unclear reasons, it
falls completely off the main trend. It also shows a
similar sensitivity (10–20 counts/M) for all of them
except for the weak 1.45 kV alanine peak. This peak is
nevertheless unresolvable by this DMA from the 1.40
kV sarcosine peak.
Peak deconvolution is a useful approach to resolve
incompletely separated peaks. Figure 3 shows the orig-
inal and deconvoluted spectra (Supporting Informa-
tion) from Figure 2a, for the unspiked urine and the 34
M spiked sarcosine samples. Area ratios between the
main peaks are 0.36 in the unspiked sample (both
S1/A1 and S2/A2) and 1.1 in the spiked sample
(again for both of them). Considering the sensitivities
estimated in Figure 2b for each of the peaks, this results
in sarcosine/alanine ratios of0.3 and 0.9, respectively.
Figure 3, therefore, illustrates the expected typical mo-
bility profile from a control (bottom) and a prostate
cancer patient (top). This quantification also implies a
60 M alanine concentration in the 1/10 diluted urine
sample, which is also roughly consistent (within order
of magnitude) with reported concentrations of alanine
in urine (270 M) [10], indicating a minimal ion
suppression effect in this particular case.
Figure 3. Deconvoluted mobility spectra for the unspiked urine
(bottom) and the same urine spiked with sarcosine (top). S stands
for sarcosine and A for alanine. Inferred sarcosine/alanine ratios
for top and bottom figures are 0.9 and 0.3, respectively.Conclusions
We separated sarcosine/alanine mixtures with an ESI-
DMA-MS system. Preliminary experiments with pure
standards indicated that electrical mobility of sarcosine
is 4.5 % higher than that of L-Alanine in nitrogen as
drift gas. Experiments on spiked urine revealed that
both isomers can also be partially resolved with mini-
mal sample preparation (analysis time 3 min). Decon-
volution of unresolved sarcosine and alanine peaks
enables their concentration ratio estimation.
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